Fresh analysis indicates that individuals who come off popular GLP-1 drugs like semaglutide or tirzepatide tend to recover lost weight much more quickly than those who end traditional lifestyle regimens.
Research printed in a major health publication demonstrates that while obese people can lose substantial amounts of their total mass while on the medication, the weight is regained at an average rate of nearly a kilo each month once they quit.
"Individuals purchasing such medications need to be aware of the danger of fast rebound weight gain when the treatment concludes," warns researcher Dr. Susan Jebb.
This pace of recovery implies a reversion to starting mass within about one and a half years.
Weighing Treatments
The study, which reviewed 37 of studies involving thousands of participants, contrasted the outcomes of the injectable medications with other pills.
Scientists point out that individuals who shed pounds through lifestyle changes alone typically see a more gradual creep back—around 0.1 kg a month—post-intervention.
The Reason for the Quick Regain
Nutrition scientists propose the way of the injections explains the amplified weight return.
These medications mimic a natural hormone called GLP-1, which moderates appetite.
"Long-term administration of the hormone concentrations several times higher than normal may cause the body to produce less of its own natural GLP-1, and could reduce sensitivity to its effects," said Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this medication leads to appetite is no longer kept in check, making binge eating far more likely."
A Lifelong Issue?
Health authorities recommend the injections for individuals with obesity-related medical conditions, alongside recommended lifestyle changes.
A number of clinicians argue that, given the high risk of relapse, the treatment should be considered ongoing.
This perspective is echoed by pharmaceutical companies, who note that the results "emphasize the persistent nature of excess weight," similar to managing conditions like hypertension.
User Experiences
Users who have stopped the medication explain a sudden return of cravings.
"I experienced a trigger activating and you're instantly extremely hungry," described an individual.
This challenge is exacerbated if individuals have not established lasting lifestyle or habit modifications during treatment.
Significant Interest
Recent estimates indicate that millions of adults in the UK have tried weight-loss jabs in the past year, with desire continuing to grow.
- Use is more common among females than males.
- The middle-aged age group shows the greatest usage rates.
- Many obtain the medications through private prescriptions rather than the NHS.
Finally, researchers caution that while these medications are potent tools for shedding pounds, they are not a permanent fix and maintained weight loss likely depends on integrated behavioural changes.
